Cubist Systematic Strategies, LLC Cv Rx, Inc. Transaction History
Cubist Systematic Strategies, LLC
- $17.3 Billion
- Q1 2024
A detailed history of Cubist Systematic Strategies, LLC transactions in Cv Rx, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 46,051 shares of CVRX stock, worth $552,151. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,051
Previous 7,995
476.0%
Holding current value
$552,151
Previous $251,000
233.86%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CVRX
# of Institutions
91Shares Held
13.8MCall Options Held
264KPut Options Held
89.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$49.2 Million15.74% of portfolio
-
Nea Management Company, LLC Timonium, MD2.37MShares$28.4 Million3.03% of portfolio
-
Black Rock Inc. New York, NY765KShares$9.17 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL619KShares$7.42 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA594KShares$7.13 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $247M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...